You can buy or sell Hancock Jaffe and other stocks, options, ETFs, and crypto commission-free!
Hancock Jaffe Laboratories, Inc. Common Stock, also called Hancock Jaffe, is a development stage medical device company, which develops biologic-based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Read More Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
52 Week High
52 Week Low
Yahoo FinanceMay 1
Hancock Jaffe Announces Successful Third Implantation for CoreoGraft Study at Texas Heart Institute
All Three Test Subjects for the Feasibility Study Have Now Been Successfully Implanted IRVINE, CA / ACCESSWIRE / May 1, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, has announced the successful third implantation of its CoreoGraftÒ pre-clinical feasibility study at the Texas Heart Institute. Bypasses using the CoreoGraft have now been successfully completed in all three test subjects. Following the surgery, flow rate...
Expected May 30, Pre-Market